Mechanistically, TSPAN9 suppresses the secretion of metastasis-associated proteins, such as MMP9, through inhibition of the ERK1/2 pathway, thereby impairing gastric cancer cell proliferation, migration and invasion [27]. The gene discussed is MMP9; the disease is gastric cancer.